Ceryx Medical Initiates First-In-Human Study of the Cysoni™ RSA Pacemaker
Ceryx Medical notes the RSA-Pace study will enroll up to 60 patients at centers in the UK, New Zealand and Australia.
- Go to the previous page
- 1
- …
- 354
- 355
- 356
- 357
- 358
- 359
- 360
- …
- 5,643
- Go to the next page
